Zdrowie i gospodarka · 12/12/2017

FDA Clears Norfloxacin Tablets for Generic Approval

The US Food and Drug Administration (FDA) has ruled that norfloxacin tablets, 400mg, were not withdrawn from the market due to safety or efficacy concerns, paving the way for potential approval of generic versions through abbreviated new drug applications (ANDAs).